Caption Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$545K Hold
100,000
﹤0.01% 1187
2025
Q4
$700K Buy
+100,000
New +$783K ﹤0.01% 1168
2025
Q1
Sell
-83,200
Closed -$756K 2025
2024
Q4
$756K Buy
83,200
+45,700
+122% +$441K 0.01% 986
2024
Q3
$344K Buy
+37,500
New +$310K 0.01% 992
2020
Q4
Sell
-40,000
Closed -$8.77M 1238
2020
Q3
$8.77M Buy
+40,000
New +$8.47M 0.21% 111
2018
Q1
Sell
-200,000
Closed -$6.97M 320
2017
Q4
$6.97M Buy
+200,000
New +$6.64M 0.72% 46

Other funds holding TDOC

Caption Management's TDOC Position: Q1 2026 in Review

Caption Management reduced its Teladoc Health (TDOC) stake by 68% in Q1 2026, selling an estimated $29K and leaving 2,439 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

Caption Management first reported a position in TDOC in Q2 2019 and has held it in 15 quarters since. The position peaked at $2.9M in Q3 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Caption Management held 2,439 shares of Teladoc Health worth $13.3K as of Q1 2026.
  • Caption Management sold 5,160 Teladoc Health shares in Q1 2026, an estimated $29K.
  • Teladoc Health made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1464 holding.
  • Caption Management first reported a position in Teladoc Health in Q2 2019 and has held it in 15 quarters since.
  • Caption Management's Teladoc Health position peaked at $2.9M in Q3 2021.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.